Cargando…
Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats
BACKGROUND: Surfactant therapy is a standard of care for preterm infants with respiratory distress and reduces the incidence of death and bronchopulmonary dysplasia in these patients. Our previous study found that mesenchymal stem cells (MSCs) attenuated hyperoxia-induced lung injury and the combina...
Autores principales: | Chou, Hsiu-Chu, Chang, Chien-Hsiang, Chen, Chien-Han, Lin, Willie, Chen, Chung-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088571/ https://www.ncbi.nlm.nih.gov/pubmed/33933128 http://dx.doi.org/10.1186/s13287-021-02335-4 |
Ejemplares similares
-
Intratracheal Administration of Endotoxin Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats
por: Shim, Jae Won, et al.
Publicado: (2008) -
Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK/STAT pathways
por: Dong, Na, et al.
Publicado: (2022) -
Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice
por: Chen, Chung-Ming, et al.
Publicado: (2023) -
The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia
por: Gharehbaghi, Manizheh Mostafa, et al.
Publicado: (2021) -
Human mesenchymal stem cells ameliorate experimental pulmonary hypertension induced by maternal inflammation and neonatal hyperoxia in rats
por: Chen, Chung-Ming, et al.
Publicado: (2017)